Oak Longevity vs He & She MD: Cost, Coaching, and Terms Compared
Quick verdict: Oak Longevity is the lower up-front cost option with one flat price for all dosages and no subscription. He & She MD bundles 1:1 clinician messaging and a coaching app, but its headline prices are six-month introductory rates that renew higher. This article compares Oak Longevity vs He & She MD across pricing, support, program terms, medication format, and regulatory notes.
See Oak Longevity pricing and options
Price structure and what you actually pay
Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month with one flat price that covers all dosages and no subscription required. He & She MD advertises semaglutide from $139/month and tirzepatide from $199/month as six-month introductory rates that renew higher after the first six months. Oak bills monthly on a non recurring basis and says three month prescriptions are billed upfront; He & She MD frames its pricing as six month terms with promotional rates that renew at larger six month prices.
View He & She MD introductory program
Coaching, clinician access, and support
Oak Longevity includes free health coaching with every plan and emphasizes a low cost offering with free shipping. He & She MD bundles a coaching app that includes 1:1 clinician messaging, GLP-1 specific guidance, and progress tracking at no extra cost during the plan term. That makes He & She MD a bundled support option while Oak prioritizes low price plus included coaching.
Check Oak Longevity coaching details
Program terms, renewals, and commitment
Oak promotes no subscriptions, no membership fees, and non recurring monthly billing where you choose to renew payment each month. Oak also notes three month prescriptions are billed upfront and no refunds are available after physician approval and once medication has shipped. He & She MD sells six month introductory rates that renew at higher six month prices, so buyers should budget for the renewal price rather than the intro price.
Medication formats, clinical review, and eligibility
Oak offers compounded semaglutide and tirzepatide and states the clinical review is asynchronous with no video call required. He & She MD offers semaglutide injections, oral semaglutide, and tirzepatide injections and requires consultation and prescription by a clinician through its platform. Both note that not all customers will qualify for a prescription and that compounded medications are not reviewed by the FDA for safety, effectiveness, or quality.
| Criteria | Oak Longevity | He & She MD |
|---|---|---|
| Semaglutide starting price | From $133/month (one flat price) | From $139/month (six month intro rate) |
| Tirzepatide starting price | From $199/month (one flat price) | From $199/month (six month intro rate) |
| Subscription & renewal | No subscriptions, non recurring billing; three month supplies billed upfront | Six month introductory rates that renew at higher six month prices |
| Coaching and clinician access | Free health coaching included | App with 1:1 clinician messaging, coaching, and tracking included |
| Clinical review & intake | Asynchronous clinician review; no video call required | Clinician consultation and prescription required through platform |
| Shipping | Free shipping with tracking | Free expedited shipping |
| Regulatory note | Compounded medications not FDA approved or reviewed | Compounded medications not reviewed by FDA; pharmacies described as USP compliant and state regulated |
What matters most: five supported differences
- Price model: Oak uses one flat price for all dosages and no subscription; He & She MD uses six month intro pricing that renews higher.
- Bundled support: He & She MD includes a coaching app with 1:1 clinician messaging and tracking; Oak includes free health coaching but not the same app structure.
- Intake style: Oak processes cases with an asynchronous clinician review and no video call; He & She MD requires clinician consultation through its platform.
- Commitment terms: Oak emphasizes month to month non recurring billing and three month prescriptions billed upfront; He & She MD sells six month program terms with promotional pricing for the first six months.
- Medication formats: He & She MD lists injectable and oral semaglutide plus injectable tirzepatide; Oak highlights compounded semaglutide and tirzepatide options with one price for all dosages.
Open He & She MD program details
Conclusion and recommendation
Oak Longevity vs He & She MD comes down to cost predictability versus bundled clinical support. Oak Longevity is best for cost conscious patients who want the lowest listed prices, one flat price for all dosages, no subscription, and an asynchronous clinical review. He & She MD is best for patients who want integrated coaching and 1:1 clinician messaging through an app and are comfortable with six month introductory rates that renew higher.
Choose Oak Longevity if you prioritize the lowest up front cost, a flat price for all dosages, no subscription, and asynchronous review.
Go to Oak Longevity to compare plans
Choose He & She MD if you want a bundled coaching app with 1:1 clinician messaging and progress tracking and accept six month introductory pricing that renews at a higher rate.